BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16755223)

  • 1. Pharmacogenomics of acute lymphoblastic leukemia.
    Kager L; Evans WE
    Curr Opin Hematol; 2006 Jul; 13(4):260-5. PubMed ID: 16755223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic strategies to improve outcome and individualize therapy in cancer: the paradigm of childhood acute lymphoblastic leukemia.
    Kager L
    J BUON; 2009 Sep; 14 Suppl 1():S181-6. PubMed ID: 19785064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of childhood acute lymphoblastic leukemia.
    Brenner TL; Pui CH; Evan WE
    Curr Opin Mol Ther; 2001 Dec; 3(6):567-78. PubMed ID: 11804271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileukemic drug effects in childhood acute lymphoblastic leukemia.
    Pottier N; Cheok M; Kager L
    Expert Rev Clin Pharmacol; 2008 May; 1(3):401-13. PubMed ID: 24422694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics in acute lymphoblastic leukemia.
    Cheok MH; Pottier N; Kager L; Evans WE
    Semin Hematol; 2009 Jan; 46(1):39-51. PubMed ID: 19100367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia.
    Davidsen ML; Dalhoff K; Schmiegelow K
    J Pediatr Hematol Oncol; 2008 Nov; 30(11):831-49. PubMed ID: 18989161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.
    Relling MV; Ramsey LB
    Hematology Am Soc Hematol Educ Program; 2013; 2013():126-30. PubMed ID: 24319173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.
    Cheok MH; Evans WE
    Nat Rev Cancer; 2006 Feb; 6(2):117-29. PubMed ID: 16491071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics of acute leukemia.
    Ansari M; Krajinovic M
    Pharmacogenomics; 2007 Jul; 8(7):817-34. PubMed ID: 18240908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics of pediatric acute lymphoblastic leukemia.
    Meeker ND; Yang JJ; Schiffman JD
    Expert Opin Pharmacother; 2010 Jul; 11(10):1621-32. PubMed ID: 20429672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in childhood acute lymphoblastic leukemia.
    Pui CH
    J Formos Med Assoc; 2004 Feb; 103(2):85-95. PubMed ID: 15083238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia.
    Pui CH; Relling MV; Evans WE
    Best Pract Res Clin Haematol; 2002 Dec; 15(4):741-56. PubMed ID: 12617874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A brief history of treatments for childhood acute lymphoblastic leukaemia].
    Leverger G; Baruchel A; Schaison G
    Bull Acad Natl Med; 2009 Oct; 193(7):1495-9; discussion 1499-500. PubMed ID: 20669630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of acute lymphoblastic leukemia treatment response.
    Cunningham L; Aplenc R
    Expert Opin Pharmacother; 2007 Oct; 8(15):2519-31. PubMed ID: 17931087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.
    Maxwell RR; Cole PD
    Curr Hematol Malig Rep; 2017 Jun; 12(3):176-186. PubMed ID: 28317081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacogenomics of acute lymphoblastic leukemia].
    Ansari M; St-Onge G; Krajinovic M
    Med Sci (Paris); 2007 Nov; 23(11):961-7. PubMed ID: 18021708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy.
    Ansari M; Krajinovic M
    Curr Opin Pediatr; 2007 Feb; 19(1):15-22. PubMed ID: 17224657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics of acute leukemia.
    Cheok MH; Lugthart S; Evans WE
    Annu Rev Pharmacol Toxicol; 2006; 46():317-53. PubMed ID: 16402908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics in pediatric leukemia.
    Paugh SW; Stocco G; Evans WE
    Curr Opin Pediatr; 2010 Dec; 22(6):703-10. PubMed ID: 20861736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment.
    Pavlovic S; Kotur N; Stankovic B; Zukic B; Gasic V; Dokmanovic L
    Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30832275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.